Implementing Tobacco Control in Dental Practice

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2006 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00297700
First received: February 24, 2006
Last updated: July 13, 2006
Last verified: July 2006
  Purpose

Our goal is to test a dentist-hygienist team intervention to help dental patients quit smoking and determine if it can be effectively and cost-effectively implemented and sustained.

Staff in half of the HMO's 14 large dental facilities will be trained to provide brief cessation advice and assistance and to encourage smokers to talk by phone with a tobacco counselor before they leave the dental office. Phone counselors will provide brief counseling, assess stage, and offer a full list of cessation services. The Active Referral intervention strategy is both practical and innovative, as it takes advantage of available resources; efficiently distributes intervention activities between dentists, hygienists, and counseling specialists; and could be delivered in individual, small, or large dental practices. This intervention is provided as part of routine care to all patients seen for annual dental and periodontal exams.Consented patients will receive a short phone survey shortly after the exam to assess smoking status, satisfaction with delivery of support services,and satisfaction with intervention. Consented patients in treatment and control facilities will be surveyed by phone at one year to re-assess smoking status and satisfaction with services.


Condition Intervention Phase
Smoking
Behavioral: Active referral
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Implementing Tobacco Control in Dental Practice

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Tobacco-cessation rates (30-day point prevalence) at one year.

Secondary Outcome Measures:
  • Process measures (e.g., 5As, and referrals)
  • Stage of change progression
  • Program costs

Estimated Enrollment: 2800
Study Start Date: May 2004
Estimated Study Completion Date: April 2007
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Kaiser Permanente (KP)member
  • 18 years of age or older
  • Receiving routine primary care in KP dental offices
  • Tobacco user at time of routine dental visit

Exclusion Criteria:

  • Non-KP member
  • Less than 18 years or age
  • Non-tobacco user
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00297700

Locations
United States, Oregon
Center for Health Research
Portland, Oregon, United States, 98606
Sponsors and Collaborators
Investigators
Principal Investigator: Jack F. Hollis, Ph.D. Kaiser Permanente Foundation Hospitals/ Center for Health Research
  More Information

Publications:
Bracht, N., Kingsbury, L. & Rissel L. A Five stage Community Organization Model for Health Promotion. In Bracht, N (Ed.). Health Promotion at the Community Level. International Educational and Professional Publisher. Thousand Oaks, California: SAGE Publications; 1999, pp. 83-104.
Drummond MF, O’Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, 2nd ed. Oxford: Oxford University Press, 1997.
Eddy DM, David Eddy ranks the tests. Harvard Health Letters 1992; July Supplement:10-11.
Farnham PG, Haddix AC. Study design. In: Haddix AC, Teutsch, Corso PS, eds. Prevention Effectiveness. New York: Oxford University Press, 2003, pp. 11-27.
Fiore MC, Bailey WC, Cohen SJ, et al. Clinical Practice Guideline Smoking Cessation. Rockville, MD: U.S. Department of Health and Human Services; 1996.
Haddix AC, Teutsch, Corso PS, eds. Prevention Effectiveness. New York: Oxford University Press, 2003.
Hollis JF. Population impact of clinician efforts to reduce tobacco use. National Cancer Institute. Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Smoking and Tobacco Control Monograph No. 10. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub. No. 00-4892, November 2000a.
Hollis JF, Vogt TM, Stevens VJ, Biglan A, Severson H, Lichtenstein E. The tobacco reduction and cancer control (TRACC) program: Team approaches to counseling in medical and dental settings. In: Burns DM, Gritz ER, eds., Tobacco and the Clinician: Interventions for Medical and Dental Practice. National Cancer Institute, Monograph 5, NIH Publication No. 94-3693, 1994.
Bernard HR, Ryan GW. Text analysis: Qualitative and quantitative methods. In: Bernard HR, editor. Handbook of Methods in Cultural Anthropology. Walnut Creek, CA: AltaMira Press; 1998.
Miller WR, Rollnick S. Motivational Interviewing. New York, NY: The Guilford Press; 1991.
Morgan DL. The Focus Group Guidebook. Thousand Oaks, CA: Sage; 1998.
Murray DM. Design and Analysis of Group Randomized Trials. Oxford, NY: The Oxford University Press; 1998.
SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002; 4:149-159.
Thun MJ, Day-Lally C, Myers DG, Calle EE, Flanders WD, Zhu B-P, Namboodiri MM, Heath CW Jr. Trends in tobacco smoking and mortalityfrom cigarette use in Cancer Prevention Studies I (1959 through 1965) and II (1982 through 1988). In: Changes in Cigarette-Related Disease Risks and Their Implication for prevention and Control. National Cancer Institute, NIH Publication No. 97-4213, 1997.
Tomar SL. Dentistry’s role in tobacco control. Journal of the American Dental Association 2001; 132:33s-35s
U.S. Department of Health and Human Services. The health benefits of smoking cessation (DHHS Publication No. (CDC) 90-8416). Washington DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1990.
Vogt TM, Lichtenstein E, Ary D, Biglan A, Danielson R, Glasgow RE, Hollis JF, Hornbrook MC, Lando H, Severson H, Stevens V. Integrating tobacco intervention into a health maintenance organization: The TRACC Program. Health Education Research 1989; 4:125-135.
Weinstein MC, Siegel JE, Gold MR,et al. for the Panel on Cost-effectiveness in Health and Medicine. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. Journal of the American Medical Association 1996; 276:1253-1258.

ClinicalTrials.gov Identifier: NCT00297700     History of Changes
Other Study ID Numbers: 5 RO1 DA017974
Study First Received: February 24, 2006
Last Updated: July 13, 2006
Health Authority: United States: Federal Government

Keywords provided by National Institute on Drug Abuse (NIDA):
Smoking
Dental
Cessation
Prevention
Control
Quitline
5A-Model
Cost-effective

ClinicalTrials.gov processed this record on September 18, 2014